Difference between revisions of "Cerwenka A, et al, J Exp Med (1999), cited as Ref 36 in DOI:10.1007/s11886-020-01292-3 (Q10545)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 1999, #quickstatements; #temporary_batch_1592504869652) |
(Created claim: DOI Identifier (P138): 10.1084/jem.189.2.423, #quickstatements; #temporary_batch_1592505001433) |
||
| Property / DOI Identifier | |||
| + | |||
| Property / DOI Identifier: 10.1084/jem.189.2.423 / rank | |||
| + | Normal rank | ||
Revision as of 18:30, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Cerwenka A, et al, J Exp Med (1999), cited as Ref 36 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection (English)
0 references
Cerwenka A
0 references
Morgan TM
0 references
Harmsen AG
0 references
Dutton RW
0 references
1999
0 references
